mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-06 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-05 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |